Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3818106 | 0.95 | ALDH1A1 (0.35) | ALDH1A1CYP3A4L3MBTL1TSHRGAA | |
| SCHEMBL17373608 | 0.86 | CYP3A4 (0.31) | ALDH1A1CYP3A4L3MBTL1TSHRGAA | |
| SCHEMBL2233429 | 0.86 | TSHR (0.50) | ALDH1A1CYP3A4L3MBTL1TSHRGAA | |
| SCHEMBL133326 | 0.86 | TSHR (0.45) | ALDH1A1CYP3A4L3MBTL1TSHRGAA | |
| SCHEMBL16369496 | 0.83 | NPSR1 (0.32) | NPSR1 | |
| SCHEMBL3630561 | 0.81 | ALDH1A1 (0.36) | ALDH1A1CYP3A4L3MBTL1TSHRGAA | |
| Phosphoric Acid SCHEMBL7044382 | 0.79 | TSHR (0.39) | ALDH1A1CYP3A4L3MBTL1TSHRGAA | |
| SCHEMBL18746465 | 0.78 | PIK3CD (0.33) | GAAMEN1KMT2A | |
| SCHEMBL5968817 | 0.77 | CYP3A4 (0.33) | ALDH1A1CYP3A4L3MBTL1TSHRLMNA | |
| SCHEMBL1296634 | 0.77 | TSHR (0.65) | ALDH1A1CYP3A4L3MBTL1TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105088770-B | A kind of core-skin spins flame-retardant anti-dripping fibre and preparation method and application | 中国人民解放军总后勤部军需装备研究所 | 2017-10-13 | — | — | CN | claimed |
| WO-2023131530-A1 | A CLEANING COMPOSITION FOR METAL SUBSTRATES PRETREATMENT AND ITS PREPARATION METHOD AND APPLICATION THEREOF | BASF COATINGS GMBH (DE) | 2023-07-13 | — | — | WO | disclosed |
| US-10004740-B2 | Prodrugs of HIV reverse transcriptase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2018-06-26 | — | — | US | disclosed |
| US-20170173015-A1 | PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2017-06-22 | — | — | US | disclosed |
| US-8741809-B2 | Liquid pyraclostrobin-containing crop protection formulations | BASF SE (DE) | 2014-06-03 | — | — | US | disclosed |
| US-20110195846-A1 | Liquid Pyraclostrobin-Containing Crop Protection Formulations | BASF SE (DE) | 2011-08-11 | — | — | US | disclosed |
| EP-2346322-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010040835-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170173015-A1 | PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS | TYMP, RNGTT, REV1 | ALDH1A1 329/4885CYP3A4 108/4885L3MBTL1 1436/4885 |
| US-10004740-B2 | Prodrugs of HIV reverse transcriptase inhibitors | TYMP, RNGTT, REV1 | ALDH1A1 329/4885CYP3A4 108/4885L3MBTL1 1436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.